Health and Safety FDA to reject medical device applications without cyberattack protection plans As many as 40 per cent of end-of-life devices have no protection at all against cyberattacks Joseph MortonMarch 31, 2023
Sleep ResMed Q4 earnings show considerable upside for sleep tech company In Q4, ResMed's revenue enjoyed a 4 per cent bump to $914.7 million, an 8 per cent increase over the previous year. Joseph MortonAugust 25, 2022